IP Library › Granted Patent US 11,534,319
Granted Patent B2
US 11,534,319 · App. 17/674,671 · Granted Dec 27, 2022

Growth stent and valve for congenital narrowings

Inventors: Dustin Armer (Costa Mesa, CA); Eason Abbott (Santa Monica, CA)
Assignee: Renata Medical, Inc.
A61F2/915A61F2/243A61F2/2418A61F2/2433A61F2/95A61F2/958A61F2/07A61F2/82A61F2/90A61F2002/91558A61F2002/91575A61F2210/0014A61F2210/0057A61F2230/0069A61F2250/001A61F2250/0039A61F2250/0082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,534,319
App. No.
17/674,671
Granted
Dec 27, 2022
Kind
B2
Abstract

A growth stent and valve and methods for making and using the same. The growth stent and valve may be delivered to treat early stage congenital lesions, while expanding to adult vessel diameters. In selected embodiments, the growth stent and valve can comprise a frame and may have a covering on some portion to prevent blood flow through a wall of the frame. The growth stent and valve advantageously can maintain radial strength across an entire range of diameters necessary to treat a narrowed lesion from birth and childhood through adulthood as the vessels grow over the lifetime of a patient.

Claims (41)

1. A catheter insertable and re-expandable growth stent for implantation in an infantile patient, comprising:

a stent frame with a plurality of frame struts each extending continuously from a proximal end region of said stent frame to a distal end region of said stent frame, adjacent frame struts defining intermediate frame cells and intersecting to form respective strut junctions by which said stent frame expands via a delivery catheter from an initial cross-section that is less than eight French for facilitating insertion via the delivery catheter into a selected lumen of the infantile patient to a first stable expanded state being configured to support the selected lumen at implantation, said stent frame in the first stable expanded state defining an internal channel with a first cross-section,

wherein said stent frame is configured to be re-expanded via subsequent introduction of a dilation catheter from the first stable expanded state to a second stable expanded state as the infantile patient grows, said stent frame in the second stable expanded state continuing to support the selected lumen and defining the internal channel with a second cross-section being larger than the first cross-section.

2. The growth stent of claim 1 , wherein the first cross-section is less than 10 millimeters.

3. The growth stent of claim 1 , wherein said stent frame is configured to be re-expanded to the second stable expanded state after the infantile patient grows to become a child.

4. The growth stent of claim 1 , wherein the second cross-section is between 8 millimeters and 15 millimeters, inclusive.

5. The growth stent of claim 1 , wherein the second cross-section is between five and six-tenths times and seven and one-half times the initial cross-section.

6. The growth stent of claim 1 , wherein the internal channel extends between the proximal and distal end regions of said stent frame, at least one of the end regions being flared radially outwardly for facilitating an engagement between said stent frame and the selected lumen or being flared radially inwardly or being dulled for reducing risk of an aneurism in the selected lumen.

7. The growth stent of claim 1 , wherein said stent frame includes a fluid-impermeable covering for preventing leaks due to ingrowth of the selected lumen as the infantile patient grows.

8. The growth stent of claim 1 , wherein said stent frame is made of stainless steel, cobalt chromium, a polymer or a combination thereof.

9. The growth stent of claim 1 , wherein said stent frame is configured to further expand from the second stable expanded state to a third stable expanded state as the infantile patient further grows, said stent frame in the third stable expanded state continuing to support the selected lumen and defining the internal channel with a third cross-section being larger than the second cross-section.

10. The growth stent of claim 9 , wherein the third cross-section is between 18 millimeters and 24 millimeters, inclusive.

11. A catheter insertable and re-expandable growth valve for implantation in an infantile patient, comprising:

a valve frame with a plurality of frame struts each extending continuously from a proximal end region of said valve frame to a distal end region of said valve frame, adjacent frame struts defining intermediate frame cells and intersecting to form respective strut junctions by which said valve frame expands via a delivery catheter from an initial cross-section that is less than eight French for facilitating insertion via the delivery catheter into a selected lumen of the infantile patient to a first stable expanded state being configured to support the selected lumen at implantation, said valve frame in the first stable expanded state defining an internal channel with a first cross-section; and

a plurality of leaflets extending from said valve frame into the internal channel,

wherein said valve frame is configured to be re-expanded via subsequent introduction of a dilation catheter from the first stable expanded state to a second stable expanded state as the infantile patient grows, said valve frame in the second stable expanded state continuing to support the selected lumen and defining the internal channel with a second cross-section being larger than the first cross-section.

12. The growth valve of claim 11 , wherein the first cross-section is less than 10 millimeters.

13. The growth valve of claim 11 , wherein said valve frame is configured to be re-expanded to the second stable expanded state after the infantile patient grows to become a child.

14. The growth valve of claim 11 , wherein the second cross-section is between 8 millimeters and 15 millimeters, inclusive.

15. The growth valve of claim 11 , wherein the second cross-section is between five and six-tenths times and seven and one-half times the initial cross-section.

16. The growth valve of claim 11 , wherein the internal channel extends between the proximal and distal end regions of said valve frame, at least one of the end regions being flared radially outwardly for facilitating an engagement between said valve frame and the selected lumen or being flared radially inwardly or being dulled for reducing risk of an aneurism in the selected lumen.

17. The growth valve of claim 11 , wherein said valve frame includes a fluid-impermeable covering for preventing leaks due to ingrowth of the selected lumen as the infantile patient grows.

18. The growth valve of claim 11 , wherein said valve frame is made of stainless steel, cobalt chromium, a polymer or a combination thereof.

19. The growth valve of claim 11 , wherein said valve frame is configured to further expand from the second stable expanded state to a third stable expanded state as the infantile patient further grows, said valve frame in the third stable expanded state continuing to support the selected lumen and defining the internal channel with a third cross-section being larger than the second cross-section.

20. The growth valve of claim 19 , wherein the third cross-section is between 18 millimeters and 24 millimeters, inclusive.

21. A method for implanting a catheter insertable and re-expandable growth stent in an infantile patient, comprising:

inserting a stent frame into a selected lumen of the infantile patient via a delivery catheter, the stent frame being in an initial cross-section that is less than eight French for facilitating insertion and having a plurality of frame struts each extending continuously from a proximal end region of the stent frame to a distal end region of the stent frame; and

expanding the stent frame via the delivery catheter from the initial cross-section to a first stable expanded state to support the selected lumen, adjacent frame struts defining intermediate frame cells and intersecting to form respective strut junctions by which the stent frame expands, the stent frame in the first stable expanded state defining an internal channel with a first cross-section,

wherein the stent frame is configured to be re-expanded via subsequent introduction of a dilation catheter from the first stable expanded state to a second stable expanded state as the infantile patient grows, the stent frame in the second stable expanded state continuing to support the selected lumen and defining the internal channel with a second cross-section being larger than the first cross-section.

22. The method of claim 21 , wherein said inserting the stent frame comprises inserting the stent frame into the selected lumen via a balloon catheter delivery system.

23. The method of claim 21 , wherein said expanding the stent frame comprises expanding the stent frame to the first stable expanded state with a first cross-section being less than 10 millimeters.

24. The method of claim 21 , wherein the stent frame is configured to be re-expanded to the second stable expanded state that is between five and six-tenths times and seven and one-half times the initial cross-section.

25. A method for manufacturing a catheter insertable and re-expandable growth stent for implantation in an infantile patient, comprising:

forming a stent frame having a plurality of frame struts each extending continuously from a proximal end region of the stent frame to a distal end region of the stent frame and being in an initial cross-section that is less than eight French for facilitating insertion into a selected lumen of the infantile patient via a delivery catheter,

wherein the stent frame is expandable via the delivery catheter from the initial cross-section to a first stable expanded state to support the selected lumen, adjacent frame struts defining intermediate frame cells and intersecting to form respective strut junctions by which the stent frame expands, the stent frame in the first stable expanded state defining an internal channel with a first cross-section, and

wherein the stent frame is re-expandable via subsequent introduction of a dilation catheter from the first stable expanded state to a second stable expanded state as the infantile patient grows, the stent frame in the second stable expanded state continuing to support the selected lumen and defining the internal channel with a second cross-section being larger than the first cross-section.

26. The method of claim 25 , wherein said forming the stent frame includes flaring at least one of the end regions of the stent frame radially outwardly, flaring at least one of the end regions of the stent frame radially inwardly, dulling at least one of the end regions of the stent frame or a combination thereof.

27. The method of claim 25 , wherein said forming the stent frame includes cutting the stent frame from a tube.

28. The method of claim 25 , further comprising electropolishing the stent frame.

29. The method of claim 25 , further comprising smoothing at least one edge of the stent frame.

30. The method of claim 25 , further comprising covering the stent frame with a fluid-impermeable material.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE STREET ADDRESS FROM 4975 MACARTHUR COURT, SUITE 1150 TO 4675 MACARTHUR COURT, SUITE 1150 PREVIOUSLY RECORDED AT REEL: 69416 FRAME: 626. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 5, 2024
From: EDWARDS LIFESCIENCES CORPORTION
To: RENATA MEDICAL, INC.
Reel/Frame 069516/0830 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: EDWARDS LIFESCIENCES CORPORTION
To: RENATA MEDICAL, INC.
Reel/Frame 069416/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2024
From: NIA, NIMA V.
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 069350/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2024
From: EDWARDS LIFESCIENCES CORPORTION
To: RENATA MEDICAL, INC.
Reel/Frame 069350/0355 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2022
From: EDWARDS LIFESCIENCES CORPORATION
To: RENATA MEDICAL, INC.
Reel/Frame 061705/0678 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2022
From: ARMER, DUSTIN; ABBOTT, EASON
To: RENATA MEDICAL, INC.
Reel/Frame 061705/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2022
From: ARMER, DUSTIN; ABBOTT, EASON
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 061699/0925 →
Continuity (5)
Continuation 17118364 · Dec 10, 2020
Continuation 16877287 · May 18, 2020
Continuation 16441201 · Jun 14, 2019
Provisional Application 62811875 · Feb 28, 2019
Related Publication 20220168123A1 · Jun 2, 2022